| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |